Reduced expression of CDKN2a/p16(INK4a) in mycosis fungoides

Archives of Dermatological Research

Volumn 291, Issue 4, 1999, Pages 207-211

  Peris, Ketty ^a   Stanta, Giorgio ^b   Fargnoli, Maria Concetta ^a   Bonin, Serena ^b   Felli, Andrea ^a   Amantea, Ada ^c   Chimenti, Sergio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

CDKN2a; Mycosis fungoides; p16(INK4a)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOT HYBRIDIZATION; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MYCOSIS FUNGOIDES; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 0032958021     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050395     Document Type: Article

References (36)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Felini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 : 1361-1392
2. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJLM (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90 : 354-371
3. Hall WW, Liu CR, Schneewind O, Takahashi H, Kaplan MH, Röupe G, Vahlne A (1991) Deleted HTLV-1 provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 253 : 317-320
4. Kanavaros P, Ioannidou D, Tzardi M, Datseris G, Katsantonis J, Delidis G, Tosca A (1994) Mycosis fungoides: expression of c-myc, p62, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 90 : 767-774
5. McGregor JM, Dublin EA, Levison DA, MacDonald DM, Smith NP, Whittaker S (1995) p53 immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol 132 : 353-358
6. Wood GS, Schaffer JM, Boni R, Dummer R, Burg G, Takeshita M, Kikuchi M (1997) No evidence of HTLV-1 proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma. Am J Pathol 150 : 667-673
7. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 : 753-756
8. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 : 436-430
9. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 : 704-707
10. INK4a. Science 267 : 249-252
11. Serrano M, Lee H.-W, Chin L, Cordon-Cardo C, Beach D, De-Pinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85 : 27-37
12. Pollock PM, Pearson JV, Hayward NK (1996) Compilation of somatic mutations of the CDKN2a gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer 15 : 77-88
13. Hirama T, Koeffler HP (1995) Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86 : 841-854
14. Siebert R, Willers CP, Opalka B (1996) Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Leuk Lymphoma 23 : 505-520
15. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1 : 686-692
16. INK4a characterize the major types of hematological malignancies. Cancer Res 57 : 837-841
17. Bunn PA, Lamberg S (1979) Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63 : 725-728
18. Stanta G, Schneider C (1991) RNA extracted from paraffinembedded human tissues is amenable to analysis by PCR amplification. Biotechniques 11 : 304-308
19. Stanta G, Bonin S (1998) RNA quantitative analysis from fixed and paraffin-embedded tissues: membrane hybridization and capillary electrophoresis. Biotechniques 24 : 271-276
20. Shibata DK, Arnheim N, Martin WJ (1988) Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 167 : 225-230
21. INK4b in non-Hodgkin's lymphomas. Blood 86 : 1534-1539
22. INK4b/MTS2 in human leukemias and lymphomas. Cancer Res 55 : 1436-1440
23. Koduru PRK, Zariwala M, Soni M, Gong JZ, Xiong Y, Broome JD (1995) Deletion of cyclin-dependent kinase 4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma. Blood 86 : 2900-2905
24. Dreyling MH, Bohlander SK, Le Beau MM, Olopade OI (1995) Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 86 : 1931-1938
25. INK4b, p53 and Rb genes in primary lymphoid malignancies. Blood 87 : 4949-4958
26. Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 89 : 272-280
27. Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H (1997) Alterations of the cyclin D1/p16-pRb pathway in mantle cell lymphoma. Cancer Res 57 : 4608-4614
28. Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MAR, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva E, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS(1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 85 : 893-901
29. Geradts J, Andriko JW, Abbondanzo SL (1998) Loss of tumor suppressor gene expression in high-grade but not low-grade non-Hodgkin's lymphomas. Am J Clin Pathol 109 : 669-674
30. Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI (1998) Codeletion of CDKN2a and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer 22 : 72-78
31. Leblanc T, Derré J, Flexor M, Le Coniat M, Leroux D, Rimokh R, Larsen C-J, Berger R (1997) FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies. Genes Chromosomes Cancer 19 : 273-277
32. INK4a) gene in primary B-cell lymphomas. Blood 86 : 2724-2731
33. Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, Kahan J, Miller CW, Koeffler HP (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Br J Haematol 91 : 139-149
34. Jamal R, Thomas NSB, Gale RE, Linch DC (1996) Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level. Leukemia 10 : 629-636
35. Delmer A, Tang R, Senamaud-Beaufort P, Paterlini P, Brechot C, Zittoun R (1995) Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4a/MTS1) gene structures and expression in acute lymphoblastic leukemias. Leukemia 9 : 1240-1245
36. Siebert R, Willers CP, Schramm A, Fosså A, Gana Dresen IM, Uppenkamp M, Nowrousian MR, Seeber S, Opalka B (1995) Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. Br J Haematol 91 : 350-354